Genomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC
|
|
- Michael Barber
- 6 years ago
- Views:
Transcription
1 Genomic Research: Issues to Consider IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC
2 Outline Key genomic terms and concepts Issues in genomic research Consent models Types of findings Returning results Privacy
3
4 Differences Between Genetic and Genomic Research Understanding the Genetic Basis of Disease Past Genetic Research Research involving genetic material (DNA, RNA, etc.) Focus on rare, single gene disorders Individual genes had large effects Minimal environmental component Family studies were vehicle for research Facilitated candidate gene approach Many genetic counselors involved in these types of studies Hypothesis driven
5 Differences Between Genetic and Genomic Research Understanding the Genetic Basis of Disease Today and Future Genomic Research Focus on common complex disorders of adulthood Multiple genes with small effects are studied Environmental component critical Gene gene interaction Genes with multiple effects Large population studies/biobanks supply patient samples and clinical information International Hap Map Project dbgap
6 Multifactorial Inheritance 2014
7 Differences Between Genetic and Genomic Research Understanding the Genetic Basis of Disease Today and Future Genomic Research Focus on common complex disorders of adulthood Multiple genes with small effects are studied Environmental component critical Gene gene interaction Genes with multiple effects Large population studies/biobanks supply patient samples and clinical information International Hap Map Project dbgap
8 Drug Response 2014
9 Pharmacogenomics 2014
10 Predicting Drug Response with Genomic Testing
11 Differences Between Genetic and Genomic Research New technologies are being used to identify some of the genetic factors involved in common disease Genome Wide Association Studies (GWAS) Whole Genome Sequencing (WGS) Gene Expression Profiling Whole exome sequencing (WES) Epigenetics Copy number variants (CNVs) Not necessarily hypothesis driven
12 Whole Genome Sequencing vs. Whole Exome Sequencing 2014
13 Whole Genome Sequencing Provides the most comprehensive collection of an individual s genetic variations but not all Does not look at variations in the entire genome Does not pick up 100% of known inherited genes (misses ~20%) Concerns about false negatives Better at detecting well known SNPs than copy number variants (regions of repeated sequence) Not always consensus on the implications of novel and rare genetic variant
14 Whole Exome Sequencing The exome is the part of the genome that mainly encodes proteins ~1% of the genome Whole exome sequencing (WES) can determine the DNA sequence of most protein encoding exons May include some DNA regions that encode RNA molecules that are not involved in protein synthesis Can be targeted to particular genes of a clinical interest.
15
16 Biobanks A collection of biological material and the associated data and information stored in an organized system, for a population or a large subset of a population
17 Biobanks Numerous biobanks throughout institutions in US, Canada, Europe, and Asia Many different models for recruiting, consenting and obtaining specimens Many biobanks in Europe and Asia are conducted country or region wide Large research studies to evaluate genetic factors and the environmental components of specific diseases Similar to biobanks but are usually disease specific Usually grant supported
18 DNA Biobanks Designed to facilitate population based research Often no single disease focus Samples may be deidentified or associated with a limited data set of PHI No direct benefit to participation No individual results Seek to provide general results Some biobanks provide biometrics Longevity of study/biobank Data sharing regulations for NIH funded projects Sharing genetic results and clinical data with other investigators to facilitate and speed discovery
19 Storage of Samples for Future Genomic Research to store unused, left over blood for future research or.an additional tube of blood to be stored for future research Incorporating storage of samples (biobanking) in consent can be a separate consent form, optional element, or requirement for participation
20 Consent Models Opt in Opt out Broad Consent Categorical Consent Specific Consent
21 Some Issues to Consider When Conducting Genomic Research Consenting Ensuring participant comprehension Interpretation of data/classification of variants Privacy of information How to handle VUS How to handle variants with clinical implications Returning results? CLIA How to handle new knowledge/information Data sharing Implication of results Family members Stigmatization Inclusion of children (< 18) Downstream effects of results
22 Genes Associated with More Than One Condition Example: ApoE Key role in transporting cholesterol and other lipids in blood circulation and central nervous system 3 variants (ApoE2, ApoE3, & ApoE4) ApoE4 is associated with risks for: Cardiovascular disease Alzheimer disease Blood brain barrier dysfunction ApoE4 may be associated with susceptibility to: Malaria Viral infections (HIV, HSV) Cancer
23 Incidental Findings Genetic variants identified that were not related to the condition being investigated. Problem: Our current ability to interpret many of these variants is inadequate
24 Interpreting Findings Classifying Variants Phenotypic implications? Clinically actionable? Dewey F. et al. JAMA, 2014;311 (10):1035
25 Variants of Uncertain Significance Example: KCNH2 Can cause drug induced QT prolongation Mutations cause LQT2
26 Considerations in Returning Results Does the researcher have a duty to return results? Blurs the distinction between the roles of the researcher versus the clinician Clinical significance / Clinically actionable Actionable genes Those with deleterious mutation(s) whose penetrance would result in specific, defined, medical recommendations both supported by evidence and, when implemented, expected to improve an outcome(s) in terms of mortality or the avoidance of significant morbidity 1 ACMG variant list CLIA Downstream effects How long to update information 1 A. Haukkala et al Public Health Genomics 2013;
27 Clinical Laboratory Improvement Amendments (CLIA) Regulates laboratory testing Multiple types of CLIA certificates based on the type of diagnostic tests performed Test results used in the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health, of human beings 1 Research laboratories that test human specimens, but no report patient specific results for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health of individual patients are exempt from CLIA U. S.C. 263a 2 42 CFR 493.3(2)
28 GINA and HIPAA Genetic Information Nondiscrimination Act Protects against the use of genetic information to discriminate in health insurance and employment Health Insurance Portability and Accountability Act Protects the privacy of healthrelated information 28
29 Summary of GINA Under GINA, group and individual health insurers cannot Use a person s genetic information to set eligibility requirements or establish premium or contribution amounts Request or require that a person undergo a genetic test Under GINA, employers cannot Use a person s genetic information in decisions about hiring, firing, job assignments, or promotions Request, require, or purchase genetic information about an employee or family member 29
30 What is Protected Under GINA Family medical history Carrier testing Prenatal genetic testing Susceptibility testing e.g., BRCA testing for breast cancer risk, testing for Huntington disease, or testing for HNPCC for colon cancer risk Analysis of tumors or other assessments of genes, mutations, or chromosomal changes 30
31 2010 Patient Protection and Affordable Care Act (ACA) Outlaws discrimination by health insurers on the basis of signs and symptoms of genetic disease Group or individual health insurance cannot establish rules for eligibility on the basis of health status, medical condition, claims experience, receipt of health care, medical history, genetic information, evidence of insurability or disability. (Patient Protection and Affordable Care Act, Pub. L. No (2010)) Beginning in 2014, the ACA will prohibit variations in premiums according to health status and genetic information
32 Certificates of Confidentiality Helps researchers protect the privacy of human subject research participants enrolled in biomedical, behavioral, clinical, and other forms of sensitive research Protects against compulsory legal demands for identifying information/characteristics of a research participant
33 Possible Future American College of Medical Genetics (ACMG) Advanced Notice of Proposed Rule Making (ANPR)
34 American College of Medical Genetics Recommendations Mutations found in 56 genes should be reported by the laboratory regardless of indication Responsibility of ordering clinician/team to provide comprehensive preand posttest counseling to the patient ~3.4% of European descent and ~1.2% of African decent adults can be expected to have actionable highly penetrant pathogenic or likely pathogenic mutations 1 Genet Med 2013:15(7): Dorschner et al. AJHG 2013:93:
35 Advanced Notice of Proposed Rulemaking (ANPR) Concerns about data protections and minimizing information risks: The nature of risk and benefits for research participants has changed with the increased use of genetic information, existing (stored) biospecimens, and medical records in research What data constitutes as identifiable and deidentified is fluid
36 Advanced Notice of Proposed Rulemaking (ANPR) Pre existing data or biospecimens: Currently research with de identified data is exempt Proposes that general (broad) consent would be required for research use of biospecimens regardless if it is associated with identifiers or not Consent for using stored samples is treated differently from other types of research
37 Summary Careful consideration and planning needs to go into any protocol involving genomic research Unanticipated issues and changing policies Thorough consenting is necessary Consult/include a genetics professional
38
39 Translating Genomic Information into Clinical Practice Why this is so challenging right now Lack of comparative effectiveness data for genomic applications Market access to genomic tests makes lack of evidence more problematic Lack of consensus on evidence requirements or thresholds for genomic test evaluation Several alternative models are have been proposed in absence of definitive data Need for alternative models for evaluating risk and benefit trade offs Traditional medical genetics models won t work Not scaleable Current consent processes and patient interactions based on one gene at atime Time needed Large amounts of data
40 DNA Microarray Analysis Most common use is for gene expression analysis A technique used to determine whether genes are turned on or off A gene is turned on if RNA is present A technique to detect sequence variations in SNPs (single nucleotide polymorphisms) Allows thousands of genes to be tested at the same time
41 Gene Expression
42 SNP Genotyping
Reporting Results and Incidental Findings to Research Participants
Reporting Results and Incidental Findings to Research Participants Jeffrey R Botkin, MD, MPH Professor of Pediatrics Chief, Division of Medical Ethics and Humanities Associate Vice President for Research
More informationGenetics/Genomics in Public Health. Role of Clinical and Biochemical Geneticists in Public Health
Genetics/Genomics in Public Health Role of Clinical and Biochemical Geneticists in Public Health Premises Human variation is vast Strength of genetic factors are a continuum from low to high Testing technology
More informationFrequently Asked Questions
Frequently Asked Questions Genetics Defined What does DNA stand for? DNA stands for deoxyribonucleic acid. This term describes the different chemical building blocks that make up the structure of DNA.
More informationExome Sequencing Exome sequencing is a technique that is used to examine all of the protein-coding regions of the genome.
Glossary of Terms Genetics is a term that refers to the study of genes and their role in inheritance the way certain traits are passed down from one generation to another. Genomics is the study of all
More informationInformed Consent for Columbia Combined Genetic Panel (CCGP) for Adults Please read the following
Informed Consent for Columbia Combined Genetic Panel (CCGP) for Adults Please read the following form carefully and discuss with your ordering physician/genetic counselor before signing consent. 1. The
More informationREQUEST FOR HEMOPHILIA B (FACTOR IX DEFICIENCY)
REQUEST FOR HEMOPHILIA B (FACTOR IX DEFICIENCY) Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION* FIRST
More informationAn innovative approach to genetic testing for improved patient care
An innovative approach to genetic testing for improved patient care Blueprint Genetics Blueprint Genetics is changing diagnostics by providing fast, affordable and comprehensive genetic knowledge Who we
More informationREQUEST FOR RETINOBLASTOMA TESTING
REQUEST FOR RETINOBLASTOMA TESTING Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION* FIRST NAME MI LAST
More informationConsent Language Does Affect Your Ability to Share
Consent Language Does Affect Your Ability to Share Tuesday, February 13, 2018 Jean Barone HRPO Director Melissa Miklos HRPO Associate Director Change in Education Units Continuing Education Units will
More informationJeffrey R Botkin, MD, MPH Professor of Pediatrics Associate Vice President for Research
Jeffrey R Botkin, MD, MPH Professor of Pediatrics Associate Vice President for Research Disclosure of Research Results Hot issue at the present time due to whole genome sequencing and imaging in research
More informationPersonalized Human Genome Sequencing
Personalized Human Genome Sequencing Dr. Stefan Platz DABT, Global Head Drug Safety & Metabolism Biomedical research: strengths & limitations of non-animal alternatives 06 December 2016 The Human Genome
More informationFIRST NAME MI LAST NAME BIRTH DATE (MM/DD/YYYY) GENDER. Specify countries: Name of person previously tested and relationship:
REQUEST FOR SITE SPECIFIC ANALYSIS [APC / MYH / TP53 / MLH1 / MSH2 / MSH6] Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS
More informationClinician s Guide to Actionable Genes and Genome Interpretation
Clinician s Guide to Actionable Genes and Genome Interpretation Brandy Bernard PhD Senior Research Scientist Institute for Systems Biology Seattle, WA Dr. Bernard s research interests are in cancer drug
More informationGenetic data and electronic health records: a discussion of ethical, logistical and technological considerations
Genetic data and electronic health records: a discussion of ethical, logistical and technological considerations Informatics Journal Club Webinar August 01, 2013 Kimberly Shoenbill, Norman Fost, Umberto
More informationPolicy Number: Title: Abstract Purpose: Policy Detail:
- 1 - Policy Number: N04202 Title: NHP/NHIC-Medical Policy-Genetic, Genotype and Genomic Testing Abstract Purpose: The purpose of this policy to provide guidance for decisions related to genetic, genotype
More informationFIRST NAME MI LAST NAME BIRTH DATE (MM/DD/YYYY) GENDER. P70.4 Neonatal hypoglycemia Q79.59 Omphalocele P08.1 Large for gestational age
REQUEST FOR BECKWITH-WIEDEMANN SYNDROME (BWS) TESTING Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION*
More informationAmerican Board of Medical Genetics and Genomics
American Board of Medical Genetics and Genomics Logbook Guidelines for Certification in Laboratory Genetics and Genomics for the 2019 Examination as of 11/10/2016 Purpose: The purpose of the logbook is
More informationGENETIC TESTING A Resource from the American College of Preventive Medicine
GENETIC TESTING A Resource from the American College of Preventive Medicine A Time Tool for Clinicians ACPM's Time Tools provide an executive summary of the most up-to-date information on delivering preventive
More informationIllumina Clinical Services Laboratory
Illumina Clinical Services Laboratory CLIA Certificate No.: 05D1092911 Illumina Clinical Services Laboratory TruGenome Technical Sequence Data Test Requisition Form The Illumina Clinical Services Laboratory
More informationFIRST NAME MI LAST NAME BIRTH DATE (MM/DD/YYYY) GENDER ANCESTRY Western/Northern European Central/Eastern European Latin American/Caribbean African
REQUEST FOR UVEAL MELANOMA-RELATED GENE PANEL TESTING: GNAQ, GNA11, AND BAP1 Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS
More informationComments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants
Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 The American Society of Human Genetics 9650 Rockville Pike Bethesda, MD 20814 24 December
More informationProposed Recommendations of the European Society of Human Genetics
Genetic Testing and Common Disorders Proposed Recommendations of the European Society of Human Genetics DRAFT version 18 May 2009, PLEASE DO NOT QUOTE Introductory considerations After the focus on monogenic
More informationPHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14
PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14 Submitted resources from physician organization representatives were mapped
More informationTestimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association
Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association Before the House Energy and Commerce Subcommittee on Health 21st Century Cures: Examining the Regulation of Laboratory
More informationNanthealth Patient Informed Consent
Patient Informed Consent Why am I being asked to give consent? You are being asked to sign this consent form because you want to have a molecular/genomic analysis performed to help your physician understand
More informationTHE HEALTH AND RETIREMENT STUDY: GENETIC DATA UPDATE
: GENETIC DATA UPDATE April 30, 2014 Biomarker Network Meeting PAA Jessica Faul, Ph.D., M.P.H. Health and Retirement Study Survey Research Center Institute for Social Research University of Michigan HRS
More informationLesson Overview. Studying the Human Genome. Lesson Overview Studying the Human Genome
Lesson Overview 14.3 Studying the Human Genome THINK ABOUT IT Just a few decades ago, computers were gigantic machines found only in laboratories and universities. Today, many of us carry small, powerful
More informationTRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS
TRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS THE DOORS ARE OPEN: FEEL FREE TO COME IN CENTOGENE UNLOCKS THE POWER OF GENETIC INSIGHTS TO IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH GENETIC
More informationWILL I GET IT? GENETIC TESTING AND ALZHEIMER DISEASE. Carla Bell, MS, CGC Genetic Counselor Wesley Medical Center
WILL I GET IT? GENETIC TESTING AND ALZHEIMER DISEASE Carla Bell, MS, CGC Genetic Counselor Wesley Medical Center Participants will learn: Modes of inheritance of genetic conditions Genes associated with
More informationGenentech, Inc., its research partners, collaborators, assignees, licensees or designees. Invitation to Participate
CONSENT AND RESEARCH AUTHORIZATION TO DONATE BLOOD AND TISSUE SAMPLES FOR FUTURE RESEARCH PURPOSES YALE UNIVERSITY SCHOOL OF MEDICINE YALE-NEW HAVEN HOSPITAL 200 FR. 4 Study Title: An Open-Label, Phase
More informationHRPP Policy No. 714 Effective Date 09/01/10 Revisions Date. Genome Wide Association Studies
Genome Wide Association Studies HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date 1.0 Purpose This policy describes how investigators at the University of South Florida (USF) and USF Affiliates
More informationCertification in Laboratory Genetics and Genomics Logbook Guidelines 2019 Examination
Certification in Laboratory Genetics and Genomics Logbook Guidelines 2019 Examination Purpose: The purpose of the logbook is to document that the applicant has had direct and meaningful involvement in
More informationSEQUENCING. M Ataei, PhD. Feb 2016
CLINICAL NEXT GENERATION SEQUENCING M Ataei, PhD Tehran Medical Genetics Laboratory Feb 2016 Overview 2 Background NGS in non-invasive prenatal diagnosis (NIPD) 3 Background Background 4 In the 1970s,
More informationqcarrier Test INFORMATION DOCUMENT
qcarrier Test INFORMATION DOCUMENT The qcarrier Test is a laboratory test developed by qgenomics, aimed at studying your genetic material. It is based on a targeted analysis of human genome fragments,
More informationYour genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health
Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, 2018 Franziska Moeckel AVP, Personalized Health Your genes. Your roadmap. Overview Inova s Precision Medicine Journey MediMap
More informationREPRODUCTIVE HEALTH. Phosphorus. Diagnostics
14 32 6 32 7 REPRODUCTIVE HEALTH Phosphorus Diagnostics Genomics, Illuminated We focus on your peace of mind. Our expert-guided assay designs, powerful data analytics, and rigorous variant interpretation
More informationApplied Bioinformatics
Applied Bioinformatics In silico and In clinico characterization of genetic variations Assistant Professor Department of Biomedical Informatics Center for Human Genetics Research ATCAAAATTATGGAAGAA ATCAAAATCATGGAAGAA
More informationOutline of Discussion
This final rule is intended to better protect human subjects involved in research, while facilitating valuable research and reducing burden, delay, and ambiguity for investigators. These revisions are
More informationPerformance of the Newly Developed Non-Invasive Prenatal Multi- Gene Sequencing Screen
1 // Performance of the Newly Developed Non-Invasive Prenatal Multi- Gene Sequencing Screen ABSTRACT Here we describe the analytical performance of the newly developed non-invasive prenatal multi-gene
More informationThe Impact of Genomics on Drug Development, Clinical Research, and Medical Practice
The Impact of Genomics on Drug Development, Clinical Research, and Medical Practice Christopher P. Austin. M.D. Senior Advisor to the Director for Translational Research National Human Genome Research
More informationSingle Nucleotide Variant Analysis. H3ABioNet May 14, 2014
Single Nucleotide Variant Analysis H3ABioNet May 14, 2014 Outline What are SNPs and SNVs? How do we identify them? How do we call them? SAMTools GATK VCF File Format Let s call variants! Single Nucleotide
More informationMolecular Diagnostics
Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R
More informationTEST REQUISITION, PATIENT INFORMATION, AND CONSENT HUDSONALPHA CLINICAL SERVICES LAB
1. Patient Information Patient Name Last TEST REQUISITION, PATIENT INFORMATION, AND CONSENT HUDSONALPHA CLINICAL SERVICES LAB HUDSONALPHA CLINICAL SERVICES LAB CANNOT ACCEPT SAMPLES FROM FLORIDA AND NEW
More informationTEST REQUISITION, PATIENT INFORMATION, AND CONSENT HUDSONALPHA CLINICAL SERVICES LABORATORY
1. Patient Information Patient Name TEST REQUISITION, PATIENT INFORMATION, AND CONSENT HUDSONALPHA CLINICAL SERVICES LABORATORY HudsonAlpha Clinical Services Lab, LLC HUDSONALPHA CLINICAL SERVICES LABORATORY
More informationPresented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego
Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Discuss the difference between DNA Genotyping and Genome Sequencing What makes you who you
More informationSlides are from Level 3 Biology Course Content Day, 7 th November Presenter: Justin O Sullivan
Slides are from Level 3 Biology Course Content Day, 7 th November 2012 Presenter: Justin O Sullivan Teachers are free to use these for teaching purposes with appropriate acknowledgement Personalized genomics
More informationGenomic Medicine for the University of Vermont Health Network
Genomic Medicine for the University of Vermont Health Network The heart and science of medicine. Debra G.B. Leonard, M.D., Ph.D. Chair & Professor, Pathology & Laboratory Medicine Robert Larner, M.D. College
More informationTEST REQUISITION, PATIENT INFORMATION, AND CONSENT HUDSONALPHA CLINICAL SERVICES LAB
1. Patient Information Patient Name Last TEST REQUISITION, PATIENT INFORMATION, AND CONSENT HUDSONALPHA CLINICAL SERVICES LAB HUDSONALPHA CLINICAL SERVICES LAB CANNOT ACCEPT SAMPLES FROM FLORIDA, NEW YORK,
More informationPOLYGENIC RISK SCORES FOR RISK ASSESSMENT
POLYGENIC RISK SCORES FOR RISK ASSESSMENT RICHARD KARLSSON LINNÉR EXPERT FORUM ON GENOMIC MEDICINE OCTOBER 23, 2018 # Het begint met een idee INTRODUCTION # Het begint met een idee GENETIC HEALTH RISKS
More informationAMERICAN BOARD OF MEDICAL GENETICS
AMERICAN BOARD OF MEDICAL GENETICS Logbook Guidelines for Certification in Clinical Molecular Genetics for the 2015 Examination Purpose: The purpose of the logbook is to document that the applicant has
More informationHuman Genetic Variation. Ricardo Lebrón Dpto. Genética UGR
Human Genetic Variation Ricardo Lebrón rlebron@ugr.es Dpto. Genética UGR What is Genetic Variation? Origins of Genetic Variation Genetic Variation is the difference in DNA sequences between individuals.
More informationThe Intersection of Genomics Research and the IDE Regulation
The Intersection of Genomics Research and the IDE Regulation Katherine Donigan, Ph.D. Personalized Medicine Staff FDA/CDRH/OIR October 19, 2017 1 In Vitro Diagnostic (IVD) Regulation Through the 1976 medical
More informationLinking Genetic Variation to Important Phenotypes: SNPs, CNVs, GWAS, and eqtls
Linking Genetic Variation to Important Phenotypes: SNPs, CNVs, GWAS, and eqtls BMI/CS 776 www.biostat.wisc.edu/bmi776/ Colin Dewey cdewey@biostat.wisc.edu Spring 2012 1. Understanding Human Genetic Variation
More informationLeveraging Informatics to Improve Health Outcomes and Value
Leveraging Informatics to Improve Health Outcomes and Value Marc S. Williams, MD Director, Genomic Medicine Institute Geisinger Health System Danville, PA 1 Topic Perspective Genomic Medicine Personalized
More informationAmerican Society of Cytopathology Core Curriculum in Molecular Biology
American Society of Cytopathology Core Curriculum in Molecular Biology American Society of Cytopathology Core Curriculum in Molecular Biology Chapter 4 Stephanie A. Hamilton, EdD, SCT, MB(ASCP) CM MD Anderson
More informationBiomedical Big Data and Precision Medicine
Biomedical Big Data and Precision Medicine Jie Yang Department of Mathematics, Statistics, and Computer Science University of Illinois at Chicago October 8, 2015 1 Explosion of Biomedical Data 2 Types
More informationData Mining for Genomic- Phenomic Correlations
Data Mining for Genomic- Phenomic Correlations Joyce C. Niland, Ph.D. Associate Director & Chair, Information Sciences Rebecca Nelson, Ph.D. Lead, Data Mining Section City of Hope National Medical Center
More informationTHE ERA OF INDIVIDUAL GENOMES. Sandra Viz Lasheras Advanced Genetics ( )
THE ERA OF INDIVIDUAL GENOMES Sandra Viz Lasheras Advanced Genetics (2017-2018) CONTENTS 1. INTRODUCTION - The genomic era - Sequencing techniques 2. PROJECTS - 1000 genomes project - Individual genome
More informationTranslational Medicine in the Era of Big Data: Hype or Real?
Translational Medicine in the Era of Big Data: Hype or Real? AAHCI MENA Regional Conference September 27, 2018 AKL FAHED, MD, MPH @aklfahed Disclosures None 2 Outline The Promise of Big Data Genomics Polygenic
More informationPATIENT INFORMATION CLINICAL INFORMATION TEST REQUESTED FIRST NAME MI LAST NAME MAIDEN NAME BIRTH DATE GENDER RACE ETHNICITY
REQUEST FOR HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT) TESTING Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION
More informationGenomes contain all of the information needed for an organism to grow and survive.
Section 3: Genomes contain all of the information needed for an organism to grow and survive. K What I Know W What I Want to Find Out L What I Learned Essential Questions What are the components of the
More informationEthics of Precision Medicine in Low to Middle Income Countries
Ethics of Precision Medicine in Low to Middle Income Countries Sola Olopade, MD, MPH Professor of Medicine Director, International Programs Faculty, MacLean Center for Clinical Ethics University of Chicago
More informationA pathogenic mutation was identified in the LDLR gene.
Hereditary High Cholesterol Test ORDERING PHYSICIAN Dr. Jenny Jones Sample Medical Group 123 Main St. Sample, CA SPECIMEN Type: Saliva Barcode: 333 234234 2343 Collected: Jul 15, 2017 Received: Jul 17,
More informationCertification in Clinical Molecular Genetics and Genomics Logbook Guidelines for 2019 Examination
Certification in Clinical Molecular Genetics and Genomics Logbook Guidelines for 2019 Examination Purpose: The purpose of the logbook is to document that the applicant has had direct and meaningful involvement
More informationData Sources and Biobanks in the Asia-Pacific Region. Wei Zhou, MD, Ph.D. Department of Epidemiology, Merck Research Laboratories October 23, 2014
Data Sources and Biobanks in the Asia-Pacific Region Wei Zhou, MD, Ph.D. Department of Epidemiology, Merck Research Laboratories October 23, 2014 1 Disclosures Wei Zhou is currently an employee of Merck
More informationVariant prioritization in NGS studies: Annotation and Filtering "
Variant prioritization in NGS studies: Annotation and Filtering Colleen J. Saunders (PhD) DST/NRF Innovation Postdoctoral Research Fellow, South African National Bioinformatics Institute/MRC Unit for Bioinformatics
More informationProfessor Jane Farrar School of Genetics & Microbiology, TCD.
Lecture 1 Genetics An Overview Professor Jane Farrar School of Genetics & Microbiology, TCD. CAMPBELL BIOLOGY Campbell, Reece and Mitchell CONCEPTS OF GENTICS Klug and Cummings A Whistle-Stop Tour of 150
More informationTotal genomic solutions for biobanks. Maximizing the value of your specimens.
Total genomic solutions for biobanks. Maximizing the value of your specimens. Unlock the true potential of your biological samples. Greater understanding. Increased value. Value-driven biobanking. Now
More informationBenefits of genetic testing. Reveal the cause of diseases
Benefits of genetic testing Reveal the cause of diseases High quality testing and good medical understanding is the most important criteria for a successful collaboration with physicians and medical specialists
More informationThe patient must address the treating physician directly if he/she has any questions or requires information regarding the test results.
Order Form 1. Ordering of the FoundationOne Service The FoundationOne Service comprises the genetic analysis of tumour tissue and the compilation of a comprehensive report on any mutations found in the
More informationEPIB 668 Genetic association studies. Aurélie LABBE - Winter 2011
EPIB 668 Genetic association studies Aurélie LABBE - Winter 2011 1 / 71 OUTLINE Linkage vs association Linkage disequilibrium Case control studies Family-based association 2 / 71 RECAP ON GENETIC VARIANTS
More informationJumping Into Your Gene Pool: Understanding Genetic Test Results
Jumping Into Your Gene Pool: Understanding Genetic Test Results Susan A. Berry, MD Professor and Director Division of Genetics and Metabolism Department of Pediatrics University of Minnesota Acknowledgment
More informationPARTICIPANT RIGHTS AND PRIVACY. Tammy Stewart, CHRC & Jenny Bernhard, CHPC, CHC
PARTICIPANT RIGHTS AND PRIVACY Tammy Stewart, CHRC & Jenny Bernhard, CHPC, CHC Presentation Outline By the end of this presentation, you will have an understanding of: The history which lead to current
More informationSample to Insight. Dr. Bhagyashree S. Birla NGS Field Application Scientist
Dr. Bhagyashree S. Birla NGS Field Application Scientist bhagyashree.birla@qiagen.com NGS spans a broad range of applications DNA Applications Human ID Liquid biopsy Biomarker discovery Inherited and somatic
More informationStudying the Human Genome. Lesson Overview. Lesson Overview Studying the Human Genome
Lesson Overview 14.3 Studying the Human Genome THINK ABOUT IT Just a few decades ago, computers were gigantic machines found only in laboratories and universities. Today, many of us carry small, powerful
More informationCorporate Medical Policy
Corporate Medical Policy Proteogenomic Testing for Patients with Cancer (GPS Cancer Test) File Name: Origination: Last CAP Review: Next CAP Review: Last Review: proteogenomic_testing_for_patients_with_cancer_gps_cancer_test
More informationCorporate Medical Policy
Corporate Medical Policy Proteogenomic Testing for Patients with Cancer (GPS Cancer Test) File Name: Origination: Last CAP Review: Next CAP Review: Last Review: proteogenomic_testing_for_patients_with_cancer_gps_cancer_test
More informationCorporate Medical Policy
Corporate Medical Policy Proteogenomic Testing for Patients with Cancer (GPS Cancer Test) File Name: Origination: Last CAP Review: Next CAP Review: Last Review: proteogenomic_testing_for_patients_with_cancer_gps_cancer_test
More information6th Form Open Day 15th July 2015
6th Form Open Day 15 th July 2015 DNA is like a computer program but far, far more advanced than any software ever created. Bill Gates Welcome to the Open Day event at the Institute of Genetic Medicine
More informationAxiom Biobank Genotyping Solution
TCCGGCAACTGTA AGTTACATCCAG G T ATCGGCATACCA C AGTTAATACCAG A Axiom Biobank Genotyping Solution The power of discovery is in the design GWAS has evolved why and how? More than 2,000 genetic loci have been
More informationThe Views of Participants in DNA Biobanks
The Views of Participants in DNA Biobanks Kelly E. Ormond, I Maureen E. Smith, II & Wendy A. Wolf III Abstract Biobanks are generally created with the long-term goal of establishing genotype-phenotype
More informationSo, just exactly when will genetics revolutionise medicine? - Part 1
So, just exactly when will genetics revolutionise medicine? - Part 1 PRO F. M A RT IN K E N N E DY D EPA RT M ENT O F PAT H O LO GY & C A R N E Y C E N T R E FO R PH A R M ACO GEN O M IC S U N IVERSIT
More informationFamilial Breast Cancer
Familial Breast Cancer SEARCHING THE GENES Samuel J. Haryono 1 Issues in HSBOC Spectrum of mutation testing in familial breast cancer Variant of BRCA vs mutation of BRCA Clinical guideline and management
More informationComputational Workflows for Genome-Wide Association Study: I
Computational Workflows for Genome-Wide Association Study: I Department of Computer Science Brown University, Providence sorin@cs.brown.edu October 16, 2014 Outline 1 Outline 2 3 Monogenic Mendelian Diseases
More informationCS273B: Deep Learning in Genomics and Biomedicine. Recitation 1 30/9/2016
CS273B: Deep Learning in Genomics and Biomedicine. Recitation 1 30/9/2016 Topics Genetic variation Population structure Linkage disequilibrium Natural disease variants Genome Wide Association Studies Gene
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature13127 Factors to consider in assessing candidate pathogenic mutations in presumed monogenic conditions The questions itemized below expand upon the definitions in Table 1 and are provided
More informationGenetics of Stroke. Daniel Woo, M.D., M.S. University of Cincinnati
Genetics of Stroke Daniel Woo, M.D., M.S. University of Cincinnati Objectives To understand the basic terms and concepts of genetics To understand how they have been applied to genetic discovery To understand
More informationAgenda. The Trends The Consumers The Companies Regulatory Environment Opportunities for Labs
Agenda Why Sophisticated Genetic Testing via Internet Sources is a Direct-to-Consumer Trend Trisha Brown, M.S., C.G.C. Vice President, Clinical Affairs DNA Direct May 14, 2008 The Trends The Consumers
More informationGENOMICS for DUMMIES
ØGC seminar 31. oktober 2013 GENOMICS for DUMMIES Torben A. Kruse Klinisk Genetisk Afdeling, Odense Universitetshospital Klinisk Institut, Syddansk Universitet Human MicroArray Center, OUH / SDU Årsag:
More informationBioresearch Monitoring Inspections in Vitro Diagnostics Devices
Seite 1 von 7 U.S. Food and Drug Administration Protecting and Promoting Your Health Bioresearch Monitoring Inspections in Vitro Diagnostics Devices TABLE OF CONTENTS Introduction Nature, Scope, & Purpose
More informationIntroduction to Bioinformatics
Introduction to Bioinformatics Richard Corbett Canada s Michael Smith Genome Sciences Centre Vancouver, British Columbia June 28, 2017 Our mandate is to advance knowledge about cancer and other diseases
More informationTissue and Biobanking
Tissue and Biobanking October 17, 2017 P. Pearl O Rourke, MD Partners HealthCare Boston, MA Agenda Promises: the importance of tissue banking Challenges Access to tissue What we do and what people know/think
More informationThe 100,000 Genomes Project Genomics Collaboration Event Finnish Residence
The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence Prof Mark Caulfield FMedSci Chief Scientist for Genomics England Barts Heart Centre William Harvey Research Institute Queen Mary
More informationPersonal Genomic Information Management and Personalized Medicine: Challenges, Current Solutions, and Roles of HIM Professionals
Personal Genomic Information Management and Personalized Medicine: Challenges, Current Solutions, and Roles of HIM Professionals Personal Genomic Information Management and Personalized Medicine: Challenges,
More informationConsiderations on Implementing the ACMG IF Recommendations: The Laboratory Perspective
Considerations on Implementing the ACMG IF Recommendations: The Laboratory Perspective Elaine Lyon, PhD Medical Director, Molecular Genetics, Associate Professor of Pathology University of Utah School
More informationarticle May 2008 Vol. 10 No. 5 BACKGROUND AND HISTORY DEFINITION OF LABORATORIES
article May 2008 Vol. 10 No. 5 Molecular genetic testing for ultra rare diseases: models for translation from the research laboratory to the CLIA-certified diagnostic laboratory S. Das, PhD 1, Sherri J.
More informationLegislation and Facilitation of Health Data in Denmark Short update. Mads Melbye, MD, DMSc Statens Serum Institut, Copenhagen, Denmark
Legislation and Facilitation of Health Data in Denmark Short update Mads Melbye, MD, DMSc Statens Serum Institut, Copenhagen, Denmark Legislation short facts Register research: exempted from informed consent
More informationAGRO/ANSC/BIO/GENE/HORT 305 Fall, 2016 Overview of Genetics Lecture outline (Chpt 1, Genetics by Brooker) #1
AGRO/ANSC/BIO/GENE/HORT 305 Fall, 2016 Overview of Genetics Lecture outline (Chpt 1, Genetics by Brooker) #1 - Genetics: Progress from Mendel to DNA: Gregor Mendel, in the mid 19 th century provided the
More informationPATIENT INFORMATION CLINICAL INFORMATION TEST REQUESTED FIRST NAME MI LAST NAME MAIDEN NAME BIRTH DATE GENDER RACE ETHNICITY
REQUEST FOR HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT) TESTING Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION
More informationLinking Genetic Variation to Important Phenotypes: SNPs, CNVs, GWAS, and eqtls
Linking Genetic Variation to Important Phenotypes: SNPs, CNVs, GWAS, and eqtls BMI/CS 776 www.biostat.wisc.edu/bmi776/ Mark Craven craven@biostat.wisc.edu Spring 2011 1. Understanding Human Genetic Variation!
More information